EC Number   |
Title |
Organism |
|---|
    1.2.1.11 | Aspartate semialdehyde dehydrogenase inhibition suppresses the growth of the pathogenic fungus Candida albicans |
Candida albicans |
| 1.2.1.11 | Aspartate semialdehyde dehydrogenase inhibition suppresses the growth of the pathogenic fungus Candida albicans |
Candida albicans CAF2-1 |
| 1.2.1.11 | Aspartate-beta-semialdeyhyde dehydrogenase as a potential therapeutic target of Mycobacterium tuberculosis H37Rv Evidence from in silico elementary mode analysis of biological network model |
Mycobacterium tuberculosis |
| 1.2.1.11 | Aspartate-beta-semialdeyhyde dehydrogenase as a potential therapeutic target of Mycobacterium tuberculosis H37Rv Evidence from in silico elementary mode analysis of biological network model |
Mycobacterium tuberculosis H37Rv |
| 1.2.1.11 | Aspartate-beta-semialdeyhyde dehydrogenase as a potential therapeutic target of Mycobacterium tuberculosis H37Rv Evidence from in silico elementary mode analysis of biological network model |
Mycobacterium tuberculosis ATCC 25618 |
| 1.2.1.11 | Elaboration of a fragment library hit produces potent and selective aspartate semialdehyde dehydrogenase inhibitors |
Streptococcus pneumoniae |
| 1.2.1.11 | Elaboration of a fragment library hit produces potent and selective aspartate semialdehyde dehydrogenase inhibitors |
Vibrio cholerae serotype O1 |
| 1.2.1.11 | Identification and validation of aspartic acid semialdehyde dehydrogenase as a new anti-Mycobacterium tuberculosis target |
Mycobacterium tuberculosis |
| 1.2.1.11 | Identification and validation of aspartic acid semialdehyde dehydrogenase as a new anti-Mycobacterium tuberculosis target |
Mycobacterium tuberculosis H37Rv |
| 1.2.1.11 | Lysine and threonine biosynthesis from aspartate contributes to Staphylococcus aureus growth in calf serum |
Staphylococcus aureus |
